Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Market Definitions
1.1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List Of Secondary Sources
1.9 List Of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Segment Snapshot
2.5 Competitive Landscape Snapshot

Chapter 3 Sepsis Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increase In Prevalence Of Sepsis
3.2.1.2 Rise In Incidence Of Hospital-Acquired Infections
3.2.1.3 Increase In The Number Of Pneumonia Cases
3.2.1.4 Approval And Launch Of Advanced Sepsis Diagnostic System
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Automated Diagnostic Instruments
3.2.2.2 Lack Of Awareness About Sepsis
3.2.3 Industry Challenges
3.2.3.1 Scientific And Clinical Challenges Associated With Sepsis
3.3 Sepsis Diagnostics: Market Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Sepsis Diagnostics – Macroeconomic Analysis

Chapter 4 Sepsis Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1 Sepsis Diagnostics Market: Product Movement Analysis
4.2 Sepsis Diagnostics Market Estimates & Forecast, By Product (USD Million)
4.2.1 Instrument
4.2.2 Blood Culture Media
4.2.3 Assay Kits And Reagents
4.2.4 Software

Chapter 5 Sepsis Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)
5.1 Sepsis Diagnostics Market: Technology Movement Analysis
5.2 Sepsis Diagnostics Market Estimates & Forecast, By Technology (USD Million)
5.2.1 Microbiology
5.2.2 Molecular Diagnostics
5.2.2.1 Polymerase Chain Reaction (Pcr)
5.2.2.2 Dna Microarrays
5.2.2.3 Syndromic Panel Testing
5.2.2.4 Others
5.2.3 Immunoassays
5.2.4 Flow Cytometry
5.2.5 Others

Chapter 6 Sepsis Diagnostics Market: Segment Analysis, By Pathogen, 2018 - 2030 (USD Million)
6.1 Sepsis Diagnostics Market: Pathogen Movement Analysis
6.2 Sepsis Diagnostics Market Estimates & Forecast, By Pathogen (USD Million)
6.2.1 Bacterial Sepsis
6.2.1.1 Gram-Positive Bacteria
6.2.1.2 Gram-Negative Bacteria
6.2.2 Fungal Sepsis
6.2.3 Viral Sepsis And Others

Chapter 7 Sepsis Diagnostics Market: Segment Analysis, By Testing Type, 2018 - 2030 (USD Million)
7.1 Sepsis Diagnostics Market: Testing Type Movement Analysis
7.2 Sepsis Diagnostics Market Estimates & Forecast, By Testing Type (USD Million)
7.2.1 Laboratory Testing
7.2.2 Point-Of-Care Testing

Chapter 8 Sepsis Diagnostics Market: Segment Analysis, By Method, 2018 - 2030 (USD Million)
8.1 Sepsis Diagnostics Market: Method Movement Analysis
8.2 Sepsis Diagnostics Market Estimates & Forecast, By Method (USD Million)
8.2.1 Automated Diagnostics
8.2.2 Conventional Diagnostics

Chapter 9 Sepsis Diagnostics Market: Segment Analysis, By End-User, 2018 - 2030 (USD Million)
9.1 Sepsis Diagnostics Market: End-User Movement Analysis
9.2 Sepsis Diagnostics Market Estimates & Forecast, By End-User (USD Million)
9.2.1 Hospitals & Clinics
9.2.2 Pathology & Reference Laboratories
9.2.3 Research Institutes And Others

Chapter 10 Sepsis Diagnostic Market: Regional Estimates And Trend Analysis, By Product, By Technology, By Pathogen, By Testing Type, By Method, & By End-User
10.1 Sepsis Diagnostic Market: Regional Outlook

Chapter 11 Competitive Landscape
11.1 Company Categorization
11.2 Company Market Positioning
11.2.1 Market Leaders
11.2.1.1 Sepsis Diagnostics Market Share Analysis, 2022
11.3 Company Profiles
11.3.1 Biomérieux Sa
                          11.3.1.1 Company Overview
                          11.3.1.2 Financial Performance
                          11.3.1.3 Product Benchmarking
                          11.3.1.4 Strategic Initiatives
11.3.2 Becton, Dickinson And Company (Bd)
                          11.3.2.1 Company Overview
                          11.3.2.2 Financial Performance
                          11.3.2.3 Product Benchmarking
                          11.3.2.4 Strategic Initiatives
11.3.3 Thermo Fisher Scientific, Inc.
                          11.3.3.1 Company Overview
                          11.3.3.2 Financial Performance
                          11.3.3.3 Product Benchmarking
                          11.3.3.4 Strategic Initiatives
11.3.4 F. Hoffmann-La Roche
                          11.3.4.1 Company Overview
                          11.3.4.2 Financial Performance
                          11.3.4.3 Product Benchmarking
                          11.3.4.4 Strategic Initiatives
11.3.5 Luminex Corporation
                          11.3.5.1 Company Overview
                          11.3.5.2 Financial Performance
                          11.3.5.3 Product Benchmarking
                          11.3.5.4 Strategic Initiatives
11.3.6 Danaher
11.3.6.1 Cepheid
                             11.3.6.1.1 Company Overview
                             11.3.6.1.2 Financial Performance
                             11.3.6.1.3 Product Benchmarking
                             11.3.6.1.4 Strategic Initiatives
11.3.6.2 Beckman Coulter, Inc.
                             11.3.6.2.1 Company Overview
                             11.3.6.2.2 Financial Performance
                             11.3.6.2.3 Product Benchmarking
                             11.3.6.2.4 Strategic Initiatives
11.3.7 Luminex Corporation
                          11.3.7.1 Company Overview
                          11.3.7.2 Financial Performance
                          11.3.7.3 Product Benchmarking
                          11.3.7.4 Strategic Initiatives
11.3.8 Bruker Corporation
                          11.3.8.1 Company Overview
                          11.3.8.2 Financial Performance
                          11.3.8.3 Product Benchmarking
                          11.3.8.4 Strategic Initiatives
11.3.9 Amara Health Analytics
                          11.3.9.1 Company Overview
                          11.3.9.2 Financial Performance
                          11.3.9.3 Product Benchmarking
                          11.3.9.4 Strategic Initiatives
11.3.10 Cepheid
                          11.3.10.1 Company Overview
                          11.3.10.2 Financial Performance
                          11.3.10.3 Product Benchmarking
                          11.3.10.4 Strategic Initiatives
11.3.11 Beckman Coulter, Inc.
                          11.3.11.1 Company Overview
                          11.3.11.2 Financial Performance
                          11.3.11.3 Product Benchmarking
                          11.3.11.4 Strategic Initiatives
11.3.12 Bruker Corporation
                          11.3.12.1 Company Overview
                          11.3.12.2 Financial Performance
                          11.3.12.3 Product Benchmarking
                           11.3.12.4 Strategic Initiatives
11.3.13 Immunexpress, Inc.
                          11.3.13.1 Company Overview
                          11.3.13.2 Financial Performance
                          11.3.13.3 Product Benchmarking
                          11.3.13.4 Strategic Initiatives
11.3.14 Koninklijke Philips N.V.
                          11.3.14.1 Company Overview
                          11.3.14.2 Financial Performance
                          11.3.14.3 Product Benchmarking
                          11.3.14.4 Strategic Initiatives